false

Deborah Phippard, PhD

Pharma industry veteran and expert at biomarker-driven clinical trial design and execution. Leader of biomarker and drug development programs for pharmaceutical and diagnostics companies, as well as the National Institutes of Health. Spearheaded the discovery of pharmacodynamic biomarkers and novel targets for inflammatory disease therapy.

• Read: Receptor Occupancy in the Era of Multispecific Therapeutics

  Translational Research - Lab Services

  Receptor Occupancy in the Era of Multispecific Therapeutics

  Jul 28, ‘26 | 6 min read

  • 

  • Deborah P.

    Jenny Z.

  Discover
• Read: From Bench to Breakthrough: How Custom Kitting Fuels Precision Trials

  Translational Research - Biomarkers

  From Bench to Breakthrough: How Custom Kitting Fuels Precision Trials

  Jul 01, ‘25 | 14 min read

  • 

  • Deborah P.

    Christie B.

  Discover
• Read: Key Strategies for Future-Proofing Gene Therapy Assays

  Translational Research - Regulatory - Assays - Gene Therapies

  Key Strategies for Future-Proofing Gene Therapy Assays

  May 01, ‘25 | 9 min read

  • 

  • Deborah P.

    Travis H.

  Discover
• Read: Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity

  Translational Research - Regulatory - Assays - Gene Therapies

  Gene Therapy Assays: Regulatory Compliance with Unified Immunogenicity

  Jan 07, ‘25 | 12 min read

  • 

  • Deborah P.

    Maham A.

  Discover
• Read: Protein Assays: Choosing the Most Effective Method for Biopharmaceutical Development

  Translational Research - Lab Services - Biomarkers

  Protein Assays: Choosing the Most Effective Method for Biopharmaceutical Development

  May 31, ‘24 | 7 min read

  • 

  • Travis H.

    Deborah P.

  Discover
• Read: 8 Best Practices for Immunogenicity Assay and Companion Diagnostic Development in AAV Gene Therapy

  Translational Research - Regulatory - Gene Therapies

  8 Best Practices for Immunogenicity Assay and Companion Diagnostic Development in AAV Gene Therapy

  Feb 05, ‘24 | 6 min read

  • 

  • Deborah P.

    Kennon D.

    Travis H.

  Discover
• Read: Advancing Clinical Development of Immuno-modulatory Therapies with Flow Cytometry-Based Receptor Occupancy Assays

  Translational Research

  Advancing Clinical Development of Immuno-modulatory Therapies with Flow Cytometry-Based Receptor Occupancy Assays

  Sep 15, ‘22 | 4 min read

  • 

  • Deborah P.

    Laura L.

  Discover

Loading...

You've reach the end Back to top